These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4403276)

  • 1. [Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs].
    Mazurowa A; Szadowska A; Szmigielski A
    Kardiol Pol; 1972; 15(2):167-75. PubMed ID: 4403276
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the combined use of beta-adrenergic blockade and antiarrhythmic drugs.
    Mazurowa A; Szadowska A; Szmigielski A; Litwinowicz A
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):280-7. PubMed ID: 4393014
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the mechanism of action of INPEA, iproveratril and oxyfedrin].
    Bosse JA; Schaum E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):221-2. PubMed ID: 4390696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental study of the anti-arrhythmic activity of some beta-blocking drugs].
    Arcangeli A; Sarcinelli L; Brusadelli S
    Acta Anaesthesiol; 1968; ():Suppl 8:335+. PubMed ID: 4393552
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of beta-adrenolytics on the isolated guinea-pig atria.
    Grodzińska L; Gryglewski R
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):133-41. PubMed ID: 4397624
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of antiarrhythmic and -receptor blocking drugs on functional refractory period and contractility of electrically stimulated guinea-pig atria].
    Reuter N; Heeg E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(3):323-33. PubMed ID: 4402232
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cuent pharmacological theory of anti-arrhythmia agents, with special reference to beta-receptor blockaders].
    Takenaka F; Takeya N
    Nihon Rinsho; 1969 Oct; 27(10):2470-8. PubMed ID: 4390982
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 9. Inotropic and metabolic effects of three beta-adrenergic receptor blocking drugs on isolated rabbit left atria.
    Levy JV; Richards V
    J Pharmacol Exp Ther; 1965 Dec; 150(3):361-9. PubMed ID: 4379079
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrophysiological analysis of action on the central nervous system of an antiadrenergic beta-blockade, butydrine].
    Enia F; Nigito A; D'Agostino V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(11):300-2. PubMed ID: 4403570
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiarrhythmic drugs: electrophysiological actions.
    Bassett AL; Hoffman BF
    Annu Rev Pharmacol; 1971; 11():143-70. PubMed ID: 4402439
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative studies in the heart-lung-preparation of dog on the action spectrum of verapamil, quinidine and some alpha- and beta-sympatholytics as well as the effect of adrenaline].
    Haas H; Igarashi T
    Arzneimittelforschung; 1968 Nov; 18(11):1373-80. PubMed ID: 5755900
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen JD; Ekue JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 4398093
    [No Abstract]   [Full Text] [Related]  

  • 14. The adrenergic-receptor blocking action of verapamil.
    Dorevitch N
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):242-50. PubMed ID: 4390919
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-arrhythmic, antianginal and cardiovascular effects of the beta receptor blocking agent TE-176 (Chinoin-103)].
    József S; János S; Judit S; Kálmán H; Dezsŏ K
    Acta Pharm Hung; 1977 Sep; 47(5):227-40. PubMed ID: 21516
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological properties of a new beta-receptor blocking agent.
    Clark B; Saameli K
    Triangle; 1970; 9(8):300-8. PubMed ID: 4397310
    [No Abstract]   [Full Text] [Related]  

  • 18. General concepts in the use of beta-blockers: the relative roles of specific and unspecific effects.
    Brunner H; Hedwall PR; Meier M
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):219-31. PubMed ID: 4397722
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relation between the changes of cellular electrogenesis and beta-blocking activity of 4 optical isomers of butydrine].
    Musso E; Taccardi B
    Atti Soc Ital Cardiol; 1969 Jan; 2():268-9. PubMed ID: 5406541
    [No Abstract]   [Full Text] [Related]  

  • 20. [The beta-adrenergic blockers as anti-arrhythmics].
    Nadal-Ginard B; Sanz G; Cárdenas M
    Arch Inst Cardiol Mex; 1970; 40(4):461-70. PubMed ID: 4394936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.